Patent Baristas

The Coalition for Patent Fairness held a conference call for the Media yesterday to announce that Senate leaders has made public statements suggesting that the Patent Reform Act (S.1145) could come up for the floor vote in mid-April.  General Counsels from companies that make up the Coalition for Patent Fairness discussed the current state of […]

The Ohio Supreme Court has ruled that a company’s confidential customer list is a protected trade secret even if a former employee retains the information purely from memory. This doesn’t change the law, a trade secret is a trade secret regardless of whether it is memorized or in a more tangible form, just clarifies that […]

Well, by a 220-175 vote the U.S. House of Representatives passed its version (H.R. 1908, the Patent Reform Act of 2007) of an overhaul of patent laws designed to trim excessive litigation and improve patent quality, giving high-tech firms what they’ve been clamoring for: a weaker patent system. If made into law, the legislation will […]

The patent reform bills (H.R. 1908 and S. 1145, the Patent Reform Acts of 2007) were favorably reported by the House and Senate Judiciary Committees prior to the August Congressional recess. According to the schedule for the House of Representatives this week, H.R. 1908 is to be considered by the House this Friday, September 7th. […]

The Patent Office Professional Association (POPA) has weighed in on the patent reform fiasco and has sent a letter to the House Judiciary Committee and a letter to the Senate Judiciary Committee opposing the Patent Reform Act of 2007 (H.R. 1908/S. 1145) and provided a copy of POPA’s position paper on the legislation. POPA believes […]

Dr. Triantafyllos Tafas, represented by Kelley, Frye and Warren LLP filed a declaratory judgment action in the Eastern District of Virginia, arguing that the new continuation rules are null and void, and is also seeking a preliminary and permanent injunction prohibiting the USPTO from putting the new rules changes into effect. Dr. Tafas is an […]

In a follow-up on our earlier discussion regarding the Supreme Court’s broad scope of the research exemption to the Integra case, the question came up asking if a patented delivery formulation — say, a sustained release formulation as opposed to a therapeutic itself — would fall within the exemption from infringement under the Food and […]

The U.S. Supreme Court will vote today whether to accept for review Zoltek Corporation v. United States, No. 06-1155. Pharmaceuticals, defense and manufacturing companies are closely watching the case, which centers on the types of protections, if any, that are available to a patent-holder whose inventions have been infringed by the Federal Government or its […]